Pharma Label OCR: 2D ACI Zero-Code Rapid Changeover for Efficiency

DaoAI 2D ACI device, leveraging high-resolution 2D imaging and deep learning secondary judgment, achieves zero-code rapid changeover for label OCR and serial code inspection in pharmaceutical production. This reduces changeover downtime for multi-variety, small-batch lines from an average of 20 minutes with traditional methods to just 5 minutes, significantly boosting production efficiency and compliance.

In the pharmaceutical industry, the accuracy and integrity of product labels and the traceability of serial codes are crucial for ensuring drug safety and regulatory compliance. With the trend towards personalized medicine and diversified market demands, pharmaceutical production is increasingly moving towards multi-variety, small-batch, and rapid iteration. This makes frequent changeovers on production lines commonplace, and each changeover means reconfiguring and debugging the inspection system. Traditional inspection solutions often struggle with this challenge, leading to prolonged production downtime due to complex programming and time-consuming debugging, severely impacting production efficiency. Especially in the production of high-value drugs, any batch recall caused by label or serial code issues can result in significant economic losses and brand reputation damage. The DaoAI 2D ACI device addresses these challenges by providing an efficient and flexible solution for pharmaceutical companies.

Pain Points: Why This Hurdle Is Difficult to Overcome

Pharmaceutical manufacturers face multiple challenges in label OCR and serial code inspection. Firstly, traditional rule-based AOI systems often have a false alarm rate as high as 5% to 10% when dealing with diverse fonts, complex backgrounds, and fluctuating print quality. This leads to substantial manual re-inspection workload; data from a mid-sized pharmaceutical plant showed that manual re-inspection accounted for over 30% of the total inspection time during peak periods. Secondly, while the missed detection rate is typically below 1%, any minor label error or missing serial code can trigger a batch recall, posing extremely high compliance risks. Thirdly, and central to this case, is the frequent changeover requirement in multi-variety, small-batch production. With traditional solutions, each product change requires engineers to manually adjust parameters and write new inspection scripts, resulting in an average changeover downtime of 20-30 minutes. On production lines with multiple changeovers per day, this cumulative downtime is significant, directly leading to a 15% to 20% reduction in production efficiency.

The root cause of these difficulties lies in the wide variety of characters on pharmaceutical labels and serial codes, including numbers, letters, and special symbols. These may also suffer from minor printing defects, character adhesion, or uneven ink, making it difficult for traditional hard-coded rules to cover all variations. Simultaneously, label material reflections, curvature effects, and image blur at high production speeds all place stringent demands on imaging quality. More critically, existing solutions generally lack 'zero-code rapid changeover' capabilities. Each new product launch or specification change necessitates intervention from specialized vision engineers, consuming significant human resources and time. This contrasts sharply with the 'precise operation and rapid adaptation' philosophy pursued by FlexiTac tactile sensing technology in industrial robot grasping and assembly, highlighting the deficiencies of traditional vision systems in flexible production.

Technical Principles

The core advantage of the DaoAI 2D ACI device lies in its combination of high-resolution 2D imaging technology and advanced deep learning secondary judgment algorithms. At the hardware level, it employs industrial-grade high-resolution cameras and customized light source modules, capable of capturing character details down to the micron level, effectively overcoming common imaging challenges such as label reflections and curved surface distortions. After image acquisition, the data is fed into the DaoAI ACI OS operating system. This system incorporates feature recognition capabilities based on visual foundation models. Utilizing APDT positive/few-shot learning technology, it requires only 1-20 good sample images to complete new product model training in just 5 minutes, achieving 'zero-code automatic programming'.

Compared to traditional rule-based AOI or manual visual inspection, the DaoAI 2D ACI device offers significant advantages. Traditional AOI relies on engineers manually setting thresholds and geometric rules, which have limited ability to recognize complex, variable defect patterns, resulting in high false alarm rates and extensive reprogramming during changeovers. Manual inspection, on the other hand, is limited by human eye fatigue and subjective judgment variations, leading to unstable detection rates and inability to meet high-speed production cycle times. The deep learning algorithms of the DaoAI 2D ACI device can autonomously learn defect features from vast amounts of data, accurately identifying even minute printing flaws, character deformations, or blurring. Moreover, its built-in semantic false alarm filtering mechanism can distinguish between true defects and non-critical background interference, significantly reducing the false alarm rate. Data from a pharmaceutical production line showed that the false alarm rate decreased from 6% to below 0.5%, substantially reducing the workload of manual re-inspection. This intelligent defect recognition and filtering capability is unparalleled by traditional methods.

Typical Application Scenarios

• **Drug Box/Bottle Label OCR Recognition and Content Verification:** The DaoAI 2D ACI device can rapidly identify textual information such as batch numbers, expiration dates, production dates, and drug names on medicine boxes or bottles, and compare them in real-time with a database to ensure consistency. The challenge lies in variations in fonts and layouts across different batches and products, as well as blurred imaging during high-speed movement.
• **Serial Code/Traceability Code Inspection and Integrity Verification:** For unique serial codes, QR codes, or barcodes on drug packaging, the DaoAI 2D ACI can inspect their print quality, integrity, readability, and verify compliance with traceability standards like GS1. Challenges include defects and smudges on tiny characters, and accurate reading on reflective or curved surfaces.
• **Anti-counterfeiting Mark and Special Character Inspection:** Many drugs use laser engraving, invisible ink, or special material anti-counterfeiting marks. The DaoAI 2D ACI, with its high-resolution imaging and deep learning capabilities, can effectively detect the integrity, position, and signs of tampering of these special marks. The difficulty often lies in these marks being subtle or requiring specific lighting to be visible.
• **Packaging Material Print Defect Inspection:** Beyond textual information, the print quality of the drug packaging material itself is crucial. The DaoAI 2D ACI can be used to detect printing defects such as ink bleed, color deviation, scratches, and stains on the surface of packaging materials, ensuring the material's appearance meets standards. The challenge is the wide variety of defects, their small size, and their similarity in color to the background.

Case Study

A mid-sized pharmaceutical plant, part of a leading pharmaceutical group, specializes in various high-value prescription and over-the-counter drugs. Its production lines frequently require switching between small batches of multiple product varieties. Before adopting the DaoAI 2D ACI device, the plant's label OCR and serial code inspection primarily relied on traditional AOI systems. Each changeover necessitated at least 20-30 minutes of downtime for parameter adjustment and program writing, leading to significant daily production efficiency losses. Furthermore, the traditional system exhibited a false alarm rate as high as 7% when dealing with certain special fonts and complex label backgrounds, requiring two operators for round-theclock manual re-inspection, incurring high labor costs.

This pharmaceutical plant deployed the DaoAI 2D ACI device on a high-speed oral liquid filling line. In the initial phase, the technical team completed system integration and preliminary debugging in less than a day. Utilizing the APDT few-shot learning function of DaoAI ACI OS, engineers trained models for new products by collecting only 5-10 good sample images for each, rapidly completing the process. Production line data showed that after the DaoAI 2D ACI was implemented, the changeover time for new products was significantly reduced, averaging only 5 minutes per changeover, representing a 75% improvement in changeover efficiency compared to traditional solutions. More importantly, the system boosted the label OCR detection rate to over 99.8% while reducing the false alarm rate to below 0.2%. This resulted in a reduction of over 90% in manual re-inspection workload, freeing up significant human resources. In this case, the DaoAI 2D ACI device not only resolved efficiency bottlenecks but also substantially enhanced product quality compliance.

With its zero-code rapid changeover capability, the DaoAI 2D ACI device provides an efficient and reliable solution for label and serial code inspection in pharmaceutical multi-variety, small-batch production, significantly reducing operational costs and compliance risks.

DaoAI Solutions and Products

The DaoAI 2D ACI device is a professional-grade solution for planar defect detection, integrating high-resolution imaging units, a high-performance computing platform, and the DaoAI ACI OS operating system. In pharmaceutical label OCR/serial code inspection scenarios, its core capabilities include: **zero-code rapid changeover**, where users can train and deploy new product models in minutes by providing a small number of good samples, leveraging ACI OS's APDT few-shot learning and visual foundation models, without writing any code; **micron-level high-precision detection**, capable of identifying minute printing defects, blurred or incomplete characters; **semantic false alarm filtering**, effectively distinguishing background interference from real defects to achieve industry-leading low false alarm rates; and **high-speed online full inspection**, meeting the high-cycle production demands of pharmaceutical lines.

In practical deployment, the DaoAI 2D ACI device offers flexible integration options, supporting SDK/API/Docker, and can be deployed 100% locally and privately, ensuring customer data security remains on-site. For complex scenarios, it can be combined with the DaoAI World global model, leveraging its unified foundation and cross-scenario generalization capabilities to achieve continuous learning and model optimization from production line feedback. This solution not only enhances detection efficiency and accuracy but, more importantly, provides pharmaceutical production lines with unprecedented flexibility, enabling them to quickly respond to market changes and reduce operating costs for multi-variety, small-batch production. In this case, the DaoAI 2D ACI device reduced changeover downtime from 20 minutes to 5 minutes and lowered the false alarm rate from 7% to below 0.2%, significantly improving production efficiency and quality compliance.

Full solution for this scenario: the full inspection solution for 2D ACI Equipment

This article was generated by AI. Customer cases are simulated scenarios based on real product capabilities and figures are illustrative; see product pages for official benchmarks.